Copper (II) complexes supported by phenyl selanyl ligands: DNA binding and molecular docking studies

Read full text Summarise with VIRAT
Authors: MOOHAMBIHAI P, SIVASUBRAMANIAN A, MAHESWARAN R
Cited by: 0
References: 27

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Copper II complexes (3a-d) with (16E) -2,6-dimethyl-N-(2-phenylquinoline-4(1H)-ylidene)-5-(phenylselanyl) pyrimidine-4-amine ligands have been developed. They have been characterised by elemental analysis and several spectroscopic studies. Absorption spectra, fluroscence investigations, and viscosity tests reveal how the copper complexes interact with the calf thymus (CT-DNA). Furthermore, the ligand's ability to inhibit acetylcholinesterase (AChE) has been studied in order to establish its efficacy in the treatment of neurodegenerative diseases. Compared to normal Rivastigmine and Galantamine, the synthesised ligand 2c shows selective inhibition (AChE and BuChE) with IC50 values of 0.18 and 3.03 μM. A molecular docking study was carried out.

Fields of Study & Subjects

Metal complexes synthesis and properties Inorganic and Organometallic Chemistry Heterocyclic Compound Synthesis and Bioactivity

Publication details

Journal / source
Indian Journal of Chemistry
Volume
65
Issue
3
Publication date
27 March 2026
Language
EN